negative regulation of exosomal secretion

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of exosomal secretion. [GO_REF:0000058, GOC:TermGenie, PMID:24105262]

Negative regulation of exosomal secretion is a complex cellular process that controls the release of exosomes, small membrane-bound vesicles that play crucial roles in intercellular communication. This regulation is essential for maintaining cellular homeostasis and preventing pathological conditions. Here's a detailed description of the biological process:

1. **Formation of Exosomes:** Exosomes originate from the inward budding of the late endosomal membrane, forming multivesicular bodies (MVBs). These MVBs contain intraluminal vesicles (ILVs), which are the precursors of exosomes.

2. **Sorting and Packaging:** The sorting and packaging of molecules destined for exosomes is crucial for their specific cargo and function. This process involves a complex interplay of protein interactions and signaling pathways.

3. **Regulation of Exosome Release:** The release of exosomes from cells is tightly controlled by several mechanisms, including:
- **Rab GTPases:** These small GTPases play critical roles in vesicle trafficking and fusion with the plasma membrane, influencing exosome secretion.
- **SNARE proteins:** These proteins mediate the fusion of vesicles with target membranes, facilitating exosome release.
- **Lipid composition:** The lipid composition of the exosomal membrane influences its stability and fusion with the plasma membrane, impacting exosome secretion.
- **Cytoskeleton:** The cytoskeleton provides structural support and facilitates the movement of exosomes towards the plasma membrane.

4. **Downstream Signaling:** Once released, exosomes can interact with recipient cells, influencing their behavior through the delivery of their cargo, including proteins, lipids, and nucleic acids.

5. **Negative Regulation:** Negative regulation of exosome secretion is essential for maintaining cellular homeostasis and preventing aberrant exosome production. This regulation can occur at different stages of the exosome biogenesis pathway:
- **Suppression of exosome biogenesis:** Certain signaling pathways and proteins can inhibit the formation of MVBs and the generation of ILVs, reducing exosome production.
- **Inhibition of exosome loading:** The sorting and packaging of cargo molecules into exosomes can be regulated, limiting the incorporation of specific proteins or nucleic acids.
- **Blockage of exosome release:** Specific proteins or signaling pathways can inhibit the fusion of exosomes with the plasma membrane, preventing their release from the cell.

6. **Pathological Implications:** Disruption of the negative regulation of exosome secretion can contribute to various diseases. Excessive exosome production can promote tumor growth, inflammation, and neurodegenerative disorders. Conversely, reduced exosome secretion can lead to impaired cell communication and disease progression.

7. **Therapeutic Potential:** Targeting the negative regulation of exosome secretion offers potential therapeutic strategies for various diseases. Modulating exosome production or release can be explored to manipulate cell communication, deliver therapeutic agents, and restore cellular homeostasis.'
"

Proteins (1)

Compounds (3)